Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin to Improve Cosmetic Outcome After Radiation in Breast Cancer
NCT00902668Phase 2Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of lovastatin in acute radiation syndrome (ARS), sponsored by Virginia Commonwealth University. Primary endpoint: Proportion of Good/Excellent Cosmetic Outcome During the First 5 Years After Radiotherapy. Started Apr 2009; status: terminated.
02
Drugs
lovastatin
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT00902668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902668.